🇺🇸 FDA
Patent

US 9931349

Steroid hormone pharmaceutical composition

granted A61KA61K31/565A61K31/57

Quick answer

US patent 9931349 (Steroid hormone pharmaceutical composition) held by Compass Therapeutics LLC expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Therapeutics LLC
Grant date
Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/565, A61K31/57, A61K47/06, A61K47/14